Observational Study of Kibow Biotics in Chronic Kidney Failure Patients

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

October 31, 2012

Conditions
Chronic Kidney Failure
Interventions
DIETARY_SUPPLEMENT

Kibow Biotics/Renadyl

Month 1, one capsule three times daily (90 colony forming units); Month 2, two capsules three times daily (180 CFU's); Month 3 \& 4, three capsules three times daily (270 CFU's). Months 5 \& 6 are washout periods, in which the patient receives no product. All parameters are still monitored by the study site during months 5 \& 6. All medical, physical, clinical, QOL and other parameters will be monitored as well.

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Thomas Jefferson University

OTHER

lead

Kibow Pharma

INDUSTRY